Skip to main content

Table 3 Multivariate analysis of factors predicting clinical remission in response to IFX induction therapy (5 mg/kg)

From: Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience

  p value Odds ratio 95% CI
Modified Truelove and Witts severity index 0.27 0.81 0.54–1.20
Negative for cytomegalovirus 0.26 1.08 0.77–19.17
Serum albumin level >35 g/L at IFX initiation 0.27 6.37 0.21–190.12
Serum CRP level at IFX initiation 0.64 1.08 0.78–1.49
Serum CRP level <5 mg/L at 2 weeks after IFX initiation 0.08 8.86 0.59–132.23
  1. IFX: infliximab, IM: immunomodulator, CRP: C-reactive protein, CI: confidence interval.